Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 28 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

3 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
7(53.8%)
Phase 4
3(23.1%)
Phase 2
2(15.4%)
Phase 1
1(7.7%)
13Total
N/A(7)
Phase 4(3)
Phase 2(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials
NCT07257458Recruiting

Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer

Role: lead

NCT07257471Recruiting

Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy

Role: lead

NCT06097000Not ApplicableRecruiting

A Study of the Safety and Efficacy of Intelligent Powered Exoskeletons in Postoperative Spinal Rehabilitation

Role: collaborator

NCT06973499Completed

Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer

Role: lead

NCT05860270Phase 4Recruiting

Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis

Role: collaborator

NCT06480214Recruiting

Research on Key Technology Development and Clinical Application of Small Interactive Spinal Endoscopic Surgery Robot

Role: collaborator

NCT03571451Unknown

A Multi-center Prospective Cohort Study Based on Peritoneal Dialysis Telemedicine-assisted Platform

Role: collaborator

NCT05673980Not ApplicableUnknown

Oral Vitamin D2 for Prevention of COVID-19

Role: collaborator

NCT04948047Unknown

Breath Combined With CT for Diagnoses of Pulmonary Nodules

Role: collaborator

NCT04419207Completed

Detecting Lung Cancer Based on Exhaled Breath

Role: collaborator

NCT04454879Phase 4Completed

Different Doses of Roxadustat Treatment for Anemia in Peritoneal Dialysis Patients

Role: collaborator

NCT05034133Phase 2Unknown

Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer

Role: lead

NCT03192800Unknown

Clinical Outcome in Patients With Spinal Dural Arteriovenous Fistulas (COPSDAVF)

Role: collaborator

NCT04287712Completed

Detection of Lung Cancer by Plasma Lipids

Role: collaborator

NCT03498768Unknown

Epidemiology and Psychosocial Evaluation of Inpatient With Lung Opacity

Role: collaborator

NCT03024749Unknown

Surgical Intervention of Spinal Arteriovenous Malformations and Fistulas

Role: collaborator

NCT03170830Not ApplicableUnknown

Diagnostic Value of CircRNA-Uck2 for Acute Myocardial Infarction

Role: lead

NCT03098914Unknown

Clinical Characteristics and Microbiology of Community-Acquired Pneumonia

Role: lead

NCT02820116Phase 2Unknown

The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation

Role: lead

NCT02415452Unknown

Researches of Retinal Artery Lesions and Acute Coronary Syndrome

Role: collaborator